Michael Crump
Impact in
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
Papers in
-
- Lymphoma Diagnosis and Treatment 210
- Hematology 46
- Hematopoietic Stem Cell Transplantation 34
- Acute Myeloid Leukemia Research 15
- Co-authors
- John G. Kuruvilla (81 shared papers)Armand Keating (59 shared papers)Melania Pintilie (29 shared papers)Richard W. C. Tsang (43 shared papers)Christian Gisselbrecht (9 shared papers)David C. Hodgson (30 shared papers)Mary Krystyna Gospodarowicz (24 shared papers)Bertrand Coiffier (9 shared papers)
- Journals
- Blood (69 papers)Journal of Clinical Oncology (31 papers)Annals of Oncology (18 papers)British Journal of Haematology (17 papers)Bone Marrow Transplantation (13 papers)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Michael Crump
308 papers receiving 13.8k citations
Michael Crump's Hit Papers
Peers
Comparison fields: 5 of 144
- Pathology and Forensic Medicine 6.8k
- Oncology 2.6k
- Hematology 992
- Genetics 481
- Cancer Research 605
Countries citing papers authored by Michael Crump
This map shows the geographic impact of Michael Crump's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Crump with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Crump more than expected).
Fields of papers citing papers by Michael Crump
This network shows the impact of papers produced by Michael Crump. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Crump. The network helps show where Michael Crump may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Crump, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 326 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study Hit paper breakdown → | 2017 | 1352 |
| 2 | Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial. Hit paper breakdown → | 2011 | 1138 |
| 3 | Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Hit paper breakdown → | 2009 | 540 |
| 4 | Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study Hit paper breakdown → | 2011 | 518 |
| 5 | Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12 Hit paper breakdown → | 2014 | 383 |
| 6 | Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial Hit paper breakdown → | 2021 | 346 |
| 7 | 2003 | 308 | |
| 8 | 2011 | 307 | |
| 9 | 2003 | 296 | |
| 10 | 2003 | 241 | |
| 11 | 2008 | 235 | |
| 12 | 2003 | 234 | |
| 13 | 2019 | 230 | |
| 14 | 2015 | 191 | |
| 15 | 2003 | 167 | |
| 16 | 2008 | 157 | |
| 17 | 2001 | 150 | |
| 18 | 1993 | 147 | |
| 19 | 2006 | 140 | |
| 20 | 2008 | 140 |
About Michael Crump
Michael Crump is a scholar working on Pathology and Forensic Medicine, Hematology, Oncology, Cancer Research and Genetics, having authored 326 papers that have together received 14.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (210 papers), Hematopoietic Stem Cell Transplantation (34 papers), Breast Cancer Treatment Studies (19 papers), Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (11 papers), CAR-T cell therapy research (8 papers), Cancer Treatment and Pharmacology (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (6.8k citations), Oncology (2.6k citations), Hematology (992 citations), Genetics (481 citations) and Cancer Research (605 citations). Michael Crump has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include John G. Kuruvilla, Armand Keating, Melania Pintilie, Richard W. C. Tsang, Christian Gisselbrecht, David C. Hodgson, Mary Krystyna Gospodarowicz, Bertrand Coiffier, Annette E. Hay and Woodrow A. Wells. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, British Journal of Haematology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.